Filing Details
- Accession Number:
- 0001225208-10-024901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-15 17:38:42
- Reporting Period:
- 2010-11-11
- Filing Date:
- 2010-11-15
- Accepted Time:
- 2010-11-15 17:38:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204551 | A Michael Mussallem | One Edwards Way Irvine CA 92614 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-11 | 10,922 | $16.08 | 270,642 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-11-11 | 10,602 | $9.20 | 281,244 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-11 | 21,524 | $65.20 | 259,720 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2010-11-11 | 10,602 | $0.00 | 10,602 | $9.20 |
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2010-11-11 | 10,922 | $0.00 | 10,922 | $16.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2003-04-03 | 2011-04-03 | No | 4 | M | Direct |
| 0 | 2005-04-03 | 2011-04-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 61,937 | Indirect | 401(k) |
Footnotes
- This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $65.10 to $65.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equities to share equivalents.
Billionaire Hedge Funds
